SB 500, the CAREER Act of 2025, would reauthorize and update two existing programs created under the SUPPORT for Patients and Communities Act: the CAREER Act treatment, recovery, and workforce support grants, and the Recovery Housing Pilot Program. The bill extends both programs through fiscal year 2030 and increases funding for the workforce-support grants from $5 million annually to $12 million annually for fiscal years 2026 through 2030. It also updates the statutory findings and eligibility framework to use more recent data from 2018 through 2022, including overdose death rates, unemployment rates, and labor force participation rates, when identifying areas of need.
The bill also expands and clarifies allowable uses of grant funds. For the workforce-support grants, recipients could use up to 5 percent of funds for transportation to work, vocational education, job training, or substance use disorder treatment and recovery services. The bill adds performance reporting requirements tied to employment and earnings outcomes under the Workforce Innovation and Opportunity Act, and it limits the Secretary of Health and Human Services from requiring or prioritizing uses of grant funds outside the activities specified in the statute. For the Recovery Housing Pilot Program, the bill extends the program’s authorization through 2030 and updates the criteria used to target communities based on current labor and overdose data.
In terms of state and federal law impact, SB 500 amends sections 7183 and 8071 of the SUPPORT for Patients and Communities Act and makes conforming changes to the Act’s table of contents and subtitle headings. It does not create a new standalone program, but it materially changes the duration, funding level, reporting requirements, and permitted uses of existing federal grant programs that support addiction recovery, employment services, reentry, and recovery housing. The practical effect is to continue federal assistance to entities serving individuals with substance use disorders, including those reentering the workforce or community after treatment or incarceration.
The available context shows generally favorable treatment of the bill, with bipartisan sponsorship from Senators McConnell, Hagerty, and Fetterman and no recorded committee debate or votes in the provided materials. The bill was introduced and referred to the Senate Committee on Banking, Housing, and Urban Affairs, suggesting it was still in the early legislative process. Because there are no transcripts or votes, there is no documented opposition in the provided record, but the bill’s policy direction indicates support for continued federal investment in addiction recovery and employment-focused interventions.
The main points of potential contention are likely to be the increased authorization level, the extension of federal programs through 2030, and the bill’s limits on administrative discretion over how grant funds are used. Some stakeholders may favor the added transportation flexibility and outcome reporting, while others may question whether the federal government should expand or continue these programs at the proposed funding level. The use of overdose, unemployment, and labor-force data to target grants may also draw scrutiny over how communities are selected and whether the criteria adequately capture local need.
SB 500 amends the SUPPORT for Patients and Communities Act to extend and revise two federal grant programs focused on substance use disorder recovery, employment, reentry, and recovery housing. It increases authorized funding for CAREER Act treatment, recovery, and workforce support grants, updates eligibility and targeting criteria using newer CDC and Bureau of Labor Statistics data, adds a limited transportation expense allowance, and requires additional employment and earnings outcome reporting. It also extends the Recovery Housing Pilot Program through 2030 and updates its statutory references and selection criteria. The bill primarily affects federal agencies, grant recipients, and service providers rather than state law directly, but it would influence state and local organizations that apply for or administer these federal funds.
The overall sentiment reflected in the bill’s sponsorship is positive and bipartisan, with support from Senators McConnell, Hagerty, and Fetterman. No committee transcript or vote record is provided, so there is no documented floor or committee opposition in the available materials. The bill appears to be framed as a continuation and modernization of existing addiction recovery and workforce programs rather than a controversial policy shift.
The most likely areas of contention are funding, federal program duration, and administrative control over grant use. Supporters may view the bill as a practical reauthorization that aligns services with current overdose and labor-market data, while critics could object to the increased authorization level, the extension through 2030, or the restriction on the Secretary’s ability to steer funds toward other activities. There may also be debate over whether transportation costs should be capped at 5 percent and whether the reporting requirements are sufficient to measure program effectiveness.